NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer

NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer is a phase 1/2, interventional study registered as NCT07224152 by M.D. Anderson Cancer Center, with a registry enrolment figure of 40 participants, started 2026-03-27 and due to reach its primary completion in 2028-08-30. Interventions recorded: NBTXR3. Conditions listed: Locally-Advanced Non-Small Cell Lung Cancer. Primary outcome: Safety and Adverse Events (AEs). Lung eligibility wording from the registry: "Biopsy proven stage I-III NSCLC". Sites: United States. No results are recorded here; the registry entry is the source.